Zimmer Biomet Holdings (ZBH) Tops Q1 EPS by 22c

Zimmer Biomet Holdings (NYSE: ZBH) reported Q1 EPS of $2.09, $0.22 better than the analyst estimate of $1.87. Revenue for the quarter came in at $2.09 billion versus the consensus estimate of $2.06 billion.

GUIDANCE:

Zimmer Biomet Holdings sees FY2026 EPS of $8.40-$8.55, versus the consensus of $8.40.

For earnings history and earnings-related data on Zimmer Biomet Holdings (ZBH) click here.

You May Also Be Interested In

• Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c
• Newton Golf Company (NWTG) Reports Q2 Loss of $0.49
• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August